Detail
| LncRNA Name | AX800134 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR, Western blot, RNAi etc. |
| Sample | hepatocellular carcinoma tissues, cell line HepG2, blood |
| Expression Pattern | up-regulated |
| Function Description | In this study, we validated the upregulated expression of AX800134 in HBV-positive HCC compared with HBV-negative HCC. |
| Pubmed ID | 29789998 |
| Year | 2018 |
| Title | The?expression?and?role?of?lncRNA?AX800134?in?hepatitis B virus-related hepatocellular carcinoma |
| External Links |
| Links for AX800134 | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.